5245 empresas coinciden
Showing 5051–5100 of 5245
| Empresa | Calificación | Precio | Bajo máximo | PER | Tamaño | Rent. | Opciones | Sector |
|---|---|---|---|---|---|---|---|---|
| D- | 0,36 US$ | -100 % | — | 2,4M US$ | — | — | Metal Fabrication | |
| F | 0,67 US$ | -97 % | — | 2,4M US$ | — | — | Information Technology Services | |
| F- | 2,46 US$ | -84 % | — | 2,4M US$ | — | — | Electrical Equipment and Parts | |
| C- | 0,63 US$ | -96 % | — | 2,3M US$ | — | — | Biotechnology | |
| F- | 0,29 US$ | -86 % | — | 2,3M US$ | — | — | Electronic Components | |
| Sin calificar | 25,47 US$ | -18 % | — | 2,3M US$ | — | — | — | |
| D | 0,74 US$ | -98 % | — | 2,3M US$ | — | — | Medical Distribution | |
| F- | 0,34 US$ | -92 % | — | 2,2M US$ | — | — | Apparel Manufacturing | |
| Sin calificar | 2,35 US$ | -76 % | — | 2,2M US$ | — | — | — | |
| F- | 0,39 US$ | -91 % | — | 2,2M US$ | — | — | Integrated Freight and Logistics | |
| Sin calificar | 1,95 US$ | -99 % | — | 2,2M US$ | — | — | Biotechnology | |
| A | 2,66 US$ | -100 % | — | 2,2M US$ | — | — | Food Distribution | |
| F- | 2,38 US$ | -97 % | — | 2,1M US$ | — | — | Diagnostics and Research | |
| Sin calificar | 3,32 US$ | -70 % | — | 2,1M US$ | — | Mensuales | Other Industrial Metals and Mining | |
| F | 0,07 US$ | -97 % | — | 2,1M US$ | — | — | Software Application | |
| D | 0,16 US$ | -88 % | 0,52 | 2,1M US$ | — | — | Integrated Freight and Logistics | |
| C- | 3,16 US$ | -99 % | — | 2,1M US$ | — | — | Entertainment | |
| F | 1,35 US$ | -91 % | — | 2M US$ | 9,6 % | — | Software Application | |
| F- | 2,01 US$ | -99 % | — | 2M US$ | — | — | Capital Markets | |
| F | 0,22 US$ | -84 % | — | 2M US$ | — | — | Specialty Industrial Machinery | |
| F- | 0,34 US$ | -98 % | — | 2M US$ | — | — | Real Estate Services | |
| C- | 0,34 US$ | -96 % | — | 2M US$ | — | — | Software Application | |
| C- | 0,85 US$ | -99 % | — | 2M US$ | — | — | Information Technology Services | |
| F | 0,91 US$ | -98 % | — | 1,9M US$ | — | — | Software Application | |
| D | 0,09 US$ | -96 % | — | 1,9M US$ | — | — | Medical Devices | |
| F- | 0,44 US$ | -98 % | — | 1,9M US$ | — | — | Biotechnology | |
| Sin calificar | 1,63 US$ | -86 % | — | 1,8M US$ | — | — | Biotechnology | |
| F- | 1,00 US$ | -80 % | — | 1,8M US$ | — | — | Internet Content and Information | |
| Sin calificar | 0,36 US$ | -99 % | — | 1,8M US$ | — | — | Conglomerates | |
| F | 0,11 US$ | -97 % | — | 1,8M US$ | — | — | Consumer Electronics | |
| D | 1,92 US$ | -99 % | — | 1,8M US$ | — | — | Software Application | |
| D- | 0,50 US$ | -90 % | — | 1,8M US$ | — | — | Biotechnology | |
| D- | 0,62 US$ | -85 % | — | 1,8M US$ | — | — | Staffing and Employment Services | |
| F | 2,28 US$ | -98 % | — | 1,8M US$ | — | — | Biotechnology | |
| Sin calificar | 3,16 US$ | -83 % | — | 1,7M US$ | — | — | Biotechnology | |
| D | 2,09 US$ | -98 % | — | 1,7M US$ | — | — | Biotechnology | |
| D- | 0,44 US$ | -84 % | — | 1,7M US$ | — | — | Specialty Retail | |
| C- | 2,00 US$ | -75 % | — | 1,7M US$ | — | — | Waste Management | |
| C- | 1,33 US$ | -95 % | — | 1,6M US$ | — | — | Consumer Electronics | |
| Sin calificar | 0,63 US$ | -97 % | — | 1,6M US$ | — | — | Biotechnology | |
| Sin calificar | 16,29 US$ | -43 % | — | 1,6M US$ | — | Mensuales | — | |
| F- | 0,65 US$ | -97 % | — | 1,6M US$ | — | — | Diagnostics and Research | |
| Sin calificar | 0,09 US$ | -99 % | — | 1,6M US$ | — | — | Software Infrastructure | |
| D- | 0,04 US$ | -100 % | — | 1,6M US$ | — | — | Specialty Business Services | |
| B- | 0,86 US$ | -95 % | — | 1,6M US$ | — | — | Biotechnology | |
| D- | 0,38 US$ | -83 % | — | 1,5M US$ | — | — | Drug Manufacturers Specialty and Generic | |
| F- | 0,27 US$ | -89 % | — | 1,5M US$ | — | — | Pollution and Treatment Controls | |
| D- | 1,24 US$ | -99 % | — | 1,5M US$ | — | — | Software Application | |
| A | 2,76 US$ | -33 % | — | 1,4M US$ | 2,6 % | Mensuales | Internet Content and Information | |
| B- | 0,41 US$ | -97 % | — | 1,4M US$ | — | — | Biotechnology |
Un filtro no es una recomendación. Cada fila cumplió la condición indicada y nada más: InspectStocks describe empresas a partir de sus propios informes ante la SEC y no aconseja comprar ni vender nada.